Co-investigateur dans l’essai clinique : ALL-S-01, essai de phase III b : Allopurinol dans la schizophrénie : Un essai randomisé administrant de l’allopurinol contre un placebo en complément d’antipsychotiques chez des patients atteints de schizophrénie ou de troubles schizo-affectifs (juin 2009-mars 2010). (Tangent data SRL, Bucarest).
Awarded Best young author at International Conference of psychiatry – 2008
Member of the American Psychiatric Association
PG training in Cognitive Behaviour Therapy in psychosis
PG training in Autistic spectrum disorders
PG training in Expertise evaluation in work capacity for mental disorders.
Multiple publications in international journals
Multiple presentations at international psychiatry conferences and congresses
Course in Transcranial Magnetic Stimulation American Psychiatric Association New York May 2018